dc.contributor | Departament de Salut |
dc.contributor.author | Programa d'Harmonització Farmacoterapèutica |
dc.date.accessioned | 2019-05-21T08:23:29Z |
dc.date.available | 2019-05-21T08:23:29Z |
dc.date.issued | 2019-02-01 |
dc.identifier.citation | Programa d'Harmonització Farmacoterapèutica. Ezetimiba/rosuvastatina per al tractament de la hipercolesterolèmia. Barcelona: Servei Català de la Salut; 2019. |
dc.identifier.uri | https://hdl.handle.net/11351/4077 |
dc.description | Ezetimibe; Statin; Hypercholesterolemia |
dc.description.abstract | Rosuvastatin (ROS) is a competitive and selective inhibitor of hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase, the limiting enzyme that generates mevalonate, a precursor of cholesterol. Increases the number of hepatic LDL receptors on the cell surface to increase the absorption and catabolism of LDL cholesterol and inhibits liver synthesis of VLDL. Ezetimiba (EZE) acts at the sterol transporter level, the Niemann-Pick C1-Like 1 (NPC1L1), responsible for the intestinal uptake of cholesterol and phytosterols so that it selectively inhibits intestinal absorption of cholesterol and sterols related vegetables. The combination of both drugs with different mechanisms produces a reduction complementary to cholesterol. |
dc.language.iso | cat |
dc.publisher | Servei Català de la Salut |
dc.relation.ispartof | Programa d'Harmonització Farmacoterapèutica, Servei Català de la Salut |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Medicaments - Assaigs clínics |
dc.subject | Hipercolesterolèmia - Tractament |
dc.subject | Ezetimiba - Ús terapèutic |
dc.subject.mesh | Rosuvastatin Calcium |
dc.subject.mesh | Drug Evaluation |
dc.subject.mesh | Hypercholesterolemia |
dc.subject.mesh | /drug therapy |
dc.title | Ezetimiba/rosuvastatina per al tractament de la hipercolesterolèmia |
dc.type | info:eu-repo/semantics/report |
dc.subject.decs | rosuvastatina cálcica |
dc.subject.decs | evaluación de medicamentos |
dc.subject.decs | hipercolesterolemia |
dc.subject.decs | /tratamiento farmacológico |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |